The Journal of Obstetrics and Gynecology of India

, Volume 69, Issue 6, pp 501–508 | Cite as

Home-Based Extended Low-Dose Oral Misoprostol in Management of First-Trimester Pregnancy Loss in Low-Resource Communities: A Randomized Trial

  • Ayman H. ShaamashEmail author
  • E. A. Khlifah
  • A. M. Esmail
  • SH. G. Abdelmonem
Original Article



To investigate the efficacy, safety and tolerability of a home-based extended low-dose oral misoprostol for management of first-trimester pregnancy loss.

Materials and Methods

A randomized trial that was conducted in the Woman’s Health University Hospital and El-eman Maternity Hospital, Assiut, Egypt. One hundred and sixty patients were included. They were randomly assigned to receive four tablets of 200 μg misoprostol vaginally (max. 800 μg-hospital group) or 12 tablets orally, one every 3 h, over 2 consecutive days (max. 2400 μg-extended low-dose home group). For failed first dose, another similar second dose was given. Primary outcome measure was the percentage of patients with ‘medically completed miscarriages’ in each group (including complete miscarriages + incomplete miscarriages with successful post-miscarriage misoprostol).


The total number of patients with ‘medically completed miscarriages’ in home group was 65/79 (82.3%), which was comparable to the hospital group (52/71 or 73.2%) (P = 0.182). However, the majority of patients in home group had significantly successful miscarriages after a single course of low-dose oral misoprostol, experienced much less heavy bleeding attacks and had less systemic side effects.


In low-resource communities, the home-based extended low-dose oral misoprostol protocol proved high efficacy, safety and tolerability in management of first-trimester pregnancy loss.


Oral misoprostol Low dose First trimester Pregnancy loss 


Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical Approval

Obtained approval of the ethical review committees of the department of Obstetrics and Gynecology and Assiut College of Medicine.

Informed Consent

Informed consent was obtained.


  1. 1.
    National Institute for Health and Care Excellence (NICE). Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage (CG154). London: NICE. 2012. Accessed 11 Nov 2018.
  2. 2.
    Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynecol Obstet. 2007;99(Suppl 2):S160–7.CrossRefGoogle Scholar
  3. 3.
    Morris JL, Winikoff B, Dabash R, et al. FIGO’s updated recommendations for misoprostol used alone in gynecology and obstetrics. Int J Gynecol Obstet. 2017;138(3):363–6.CrossRefGoogle Scholar
  4. 4.
  5. 5.
    Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 2002;17:332–6.CrossRefGoogle Scholar
  6. 6.
    Saraswat L, Ashok PW, Mathur M. Medical management of miscarriage. Obstet Gynaecol. 2014;16:79–85.Google Scholar
  7. 7.
    Wu HL, Marwah S, Wang P, et al. Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis. Sci Rep. 2017;7(1):1664.CrossRefGoogle Scholar
  8. 8.
    Metwaly AB, Abbas AM, Al-Sakkaf M. The use of single dose of oral misoprostol (600 µg) at home in management of first trimester miscarriages in El-Mukala, Yemen. Int J Reprod Contracept Obstet Gynecol. 2017;5(5):1360–3.Google Scholar
  9. 9.
    Benchamanon R, Phupong V. Effectiveness of a single dose of oral misoprostol 600 μg for treatment in early pregnancy failure. J Obstet Gynaecol. 2014;34:726–9.CrossRefGoogle Scholar
  10. 10.
    Gupta S, Sharma R, Rizvi S. Study on use of oral misoprostol for medical evacuation of missed abortion. Int J Sci Res. 2017;6(10):604–5.Google Scholar
  11. 11.
    Nazir Q, Habib S, Sultana R, et al. Success and safety of misoprostol for treatment of early pregnancy failure. J Ayub Med Coll Abbottabad. 2018;30(2):245–7.PubMedGoogle Scholar
  12. 12.
    Marwah S, Gupta S, Batra NP, et al. A comparative study to evaluate the efficacy of vaginal vs oral prostaglandin E1 analogue (misoprostol) in management of first trimester missed abortion. J Clin Diagn Res JCDR. 2016;10(5):QC14.PubMedGoogle Scholar
  13. 13.
    Tang OS, Schweer H, Lee SW, et al. Pharmacokinetics of repeated doses of misoprostol. Hum Reprod. 2009;24:1862–9.CrossRefGoogle Scholar
  14. 14.
    Arain RF, Arain RF. Use of misoprostol in missed abortion—a double edged sword in anemia prevailing countries. IOSR J Dent Med Sci (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 16, Issue 3 Ver. VI; 2017. p. 100–103.Google Scholar
  15. 15.
    Zhang J, Gilles JM, Barnhart K, et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005;353:761–9.CrossRefGoogle Scholar

Copyright information

© Federation of Obstetric & Gynecological Societies of India 2019

Authors and Affiliations

  • Ayman H. Shaamash
    • 1
    Email author
  • E. A. Khlifah
    • 1
  • A. M. Esmail
    • 1
  • SH. G. Abdelmonem
    • 2
  1. 1.Department of Obstetrics and Gynecology, Woman’s Health Hospital, Faculty of MedicineAssiut UniversityAssiutEgypt
  2. 2.Department of Obstetrics and Gynecology, El eman HospitalMinistry of HealthAssiut CityEgypt

Personalised recommendations